[Eye changes in neurodermatitis disseminata].
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002386:Cataract / Q000209:etiology; D002387:Cataract Extraction; D003231:Conjunctivitis / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D003315:Cornea / Q000473:pathology; D003348:Cortisone / Q000627:therapeutic use; D004803:Eosinophilic Granuloma / Q000209:etiology; D004804:Eosinophils; D004847:Epithelial Cells; D005128:Eye Diseases / Q000209:etiology*; D005260:Female; D006801:Humans; D007637:Keratoconjunctivitis / Q000188:drug therapy / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009450:Neurodermatitis / Q000150:complications* / Q000473:pathology; D012163:Retinal Detachment / Q000209:etiology / Q000601:surgery; D014822:Vitreous Body / Q000601:surgery
D000900:Anti-Bacterial Agents; D003348:Cortisone
Augenveränderungen bei Neurodermitis disseminata.